LeafNLP Demos
Back to explore

Report #2864797

Received Oct 10, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
ID
Recovered
Unknown
Vaccinated
Sep 1, 2025
Onset
Sep 1, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNK—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

improper schedule of vaccine administered; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose in APR-2024). In SEP-2025, the patient received the 2nd dose of Shingrix. In SEP-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: improper schedule of vaccine administered). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK receipt date: 25-SEP-2025 The batch number was not provided, and we are unable to contact the reporter.